UNSPSC 51453001: Piperazine

This classification denotes an antihelminthic agent with the molecular formula C4H10N2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 1RTM4PAL0V, chemically known as 1,4-piperazine but generally known as piperazine, which bears US NIH Compound Identifier 4837. European Medicines Agency schedules Piperazine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB03841MIG. World Health Organization schedules piperazine in its Anatomical Therapeutic Chemical (ATC) Classification.

Most nations schedule piperazine under HS 29335990 and SITC 51576. As of Q4 2014, PIPERAZINE remains the US FDA Preferred Term for this commodity. Piperazine bears US NLM identifiers UMLS ID C0031957 and NCI Concept Code C61892. SMILES: C1CNCCN1.

UNSPSC 51453001 Piperazine is a Commodity code that nominally identifies a single chemical compound, but the state and local opportunities tagged under it reflect actual pharmaceutical procurement covering a broader range of pharmaceutical products and systems. Recent solicitations show state and local governments purchasing pharmaceutical supplies through piggyback and cooperative purchasing arrangements, often for public health and emergency response purposes. The Illinois Department of Public Health and Seminole County, Florida represent the kinds of issuing bodies active under this code — state health departments and county health or emergency services divisions sourcing finished pharmaceutical products and related systems rather than raw chemical inputs.

Illinois and Florida are the states showing recent activity under this code. The Illinois Department of Public Health awarded a $2,999,999.11 pharmaceutical warehouse piggyback contract to Chartwell Rx LLC through the MMCAP Infuse consortium on August 28, 2026 (IFB 26482DPHPREPDB53392) for Doxycycline Hyclate 100mg tablets and Ciprofloxacin Hydrochloride 500mg tablets over a 12-month initial term with renewal options through year 3. Seminole County, Florida posted an IFB (IFB60459723LAS) on June 30, 2026 with a July 26, 2023 deadline seeking 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually with quarterly deliveries to the Seminole County Community Health Building, under a two-year term with one-year renewal option and FEMA funding potential.